Wednesday, November 16 at 1:00PM EST

Please join Parent Project Muscular Dystrophy and NS Pharma (US subsidiary of Nippon Shinyaku, Co.,Ltd) as we host a webinar Wednesday, November 16th at 1:00 PM EST to discuss NS Pharma's Exon 53 Skipping Program.

Dr. Clemens and Lauren Morgenroth will review data from the Phase I study conducted in Japan and will present the study design for the trial that is opening in the US later this month.

Speakers:

• Abby Bronson
  Senior Vice President of Research Strategy, Parent Project Muscular Dystrophy
• Paula R. Clemens, MD
  Study Chair, NS-065/NCNP-01-201
  Medical Director, CINRG
  Professor and Vice Chair, Neurology, University of Pittsburgh School of Medicine
  Division Chief, Neurology Service, VA Pittsburgh Healthcare System
• Lauren P. Morgenroth, MS, CGC
  Operations Director for the study Clinical Project Management Team, NS-065/NCNP-01-201
  Chief Operating Officer, TRiNDS
  Adjunct Instructor, Human Genetics, University of Pittsburgh School of Public Health

To Participate:

1. Visit ReadyTalk.com and use participant code 9449985. (Be sure to test your computer beforehand)
2. Audio Dial-In Information:
   • U.S. & Canada: Dial 1.866.740.1260 and use the Access Code 9449985
   • Outside the U.S. and Canada: Lookup your number

Submit Questions:

Please submit questions in advance to info@parentprojectmd.org, with “NS Pharma Webinar” in the subject line by noon on Monday, 11/14.